Pulse Brain · Growing Health Evidence Index
Tier 4 — Narrative / commentaryPeer-reviewed

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, Andrew B. Buroker, Zachary D. Goldberger, Ellen J. Hahn, Cheryl Dennison Himmelfarb, Amit Khera, Donald M. Lloyd‐Jones, John W. McEvoy, Erin D. Michos, Michael D. Miedema, Daniel Muñoz, Sidney C. Smith, Salim S. Virani, Kim A. Williams, Joseph Yeboah, Boback Ziaeian

Circulation · 2019

Read source ↗ All evidence

Summary

This 2019 American College of Cardiology and American Heart Association guideline establishes that promotion of a healthy lifestyle throughout life is the cornerstone of cardiovascular disease prevention, supported by team-based care and individualised risk assessment. For adults aged 40–75 years, the guideline recommends 10-year ASCVD risk estimation with clinician–patient discussion before pharmacological therapy initiation. Specific recommendations include consumption of a diet emphasising vegetables, fruits, nuts, whole grains, and lean protein whilst minimising trans fats and processed foods; engagement in 150 minutes weekly of moderate-intensity or 75 minutes of vigorous-intensity physical activity; and assessment and support for tobacco cessation at every healthcare visit.

Regional applicability

These are United States guidelines from the American College of Cardiology and American Heart Association, reflecting US clinical practice standards and healthcare systems. The dietary recommendations (emphasis on vegetables, fruits, whole grains, lean protein) and physical activity targets are broadly applicable to United Kingdom population health contexts, though UK practitioners should reference NICE guidelines and local implementation frameworks; the ASCVD risk calculator is US-calibrated and may require adaptation for UK population risk profiles.

Key measures

10-year atherosclerotic cardiovascular disease (ASCVD) risk estimation; lifestyle factors (diet quality, physical activity, tobacco use); pharmacological interventions (antihypertensive therapy, statins, aspirin); management of type 2 diabetes; coronary artery calcium scanning; social determinants of health

Outcomes reported

This guideline synthesises evidence-based recommendations for primary prevention of atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation across the adult population. It provides clinical recommendations on lifestyle interventions, risk assessment, pharmacological therapies, and management of type 2 diabetes.

Theme
Policy, governance & rights
Subject
Other / interdisciplinary
Study type
Guideline
Study design
Guideline
Source type
Peer-reviewed study
Status
Published
Geography
United States
System type
Human clinical
DOI
10.1161/cir.0000000000000677
Catalogue ID
SNmqvuaa1f-x0kz6k

Topic tags

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.